These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Digoxin removal from a patient with renal failure by hemoperfusion with Amberlite XAD-4 resin. Hoy W; Gibson TP; Biddle T Artif Organs; 1979 May; 3(2):124-6. PubMed ID: 533394 [TBL] [Abstract][Full Text] [Related]
3. Digoxin removal from an anephric patient by hemoperfusion over XAD-4. Gibson TP; Nelson HA; Ivanovich P Artif Organs; 1978 Nov; 2(4):398-401. PubMed ID: 743014 [TBL] [Abstract][Full Text] [Related]
4. Advanced digoxin toxicity in renal failure: treatment with charcoal hemoperfusion. Marbury T; Mahoney J; Juncos L; Conti R; Cade R South Med J; 1979 Mar; 72(3):279-81. PubMed ID: 424817 [TBL] [Abstract][Full Text] [Related]
5. [Massive digitalis poisoning. Treatment by hemoperfusion on Amberlite XAD-4 resin]. Gosselin B; Mathieu D; Chopin C; Wattel F; Dupuis B; Boidein M Rev Med Interne; 1981 Oct; 2(3):313-23. PubMed ID: 7291786 [No Abstract] [Full Text] [Related]
6. A major endogenous ligand substance involved in renal failure. Mabuchi H; Nakahashi H Nephron; 1988; 49(4):277-80. PubMed ID: 3412543 [TBL] [Abstract][Full Text] [Related]
7. Amikacin is not removed by XAD-4 hemoperfusion. Hoy WE Artif Organs; 1982 May; 6(2):207-8. PubMed ID: 7125965 [No Abstract] [Full Text] [Related]
8. Resin hemoperfusion for drug intoxication--an update. Raja RM Int J Artif Organs; 1986 Sep; 9(5):319-22. PubMed ID: 2430899 [TBL] [Abstract][Full Text] [Related]
9. Delayed digoxin toxicity following discontinuance in acute renal failure. Ho AM; Fraser IM; Suria DD Can J Anaesth; 1987 Mar; 34(2):178-81. PubMed ID: 3829306 [TBL] [Abstract][Full Text] [Related]
10. Acute intoxication with diisopyramide: clinical and experimental study by hemoperfusion an Amberlite XAD 4 resin. Gosselin B; Mathieu D; Chopin C; Wattel F; Dupuis B; Haguenoer JM; Desprez M Clin Toxicol; 1980 Oct; 17(3):439-49. PubMed ID: 7449357 [TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 6,348 instances of blood dialysis (author's transl)]. Liao LT Zhonghua Nei Ke Za Zhi; 1981 Jun; 20(6):326-30. PubMed ID: 7318584 [No Abstract] [Full Text] [Related]
12. Influence of hemoperfusion with XAD-4 resin on the concentration of biologic constituents in the blood. Stein G; Sperschneider H; Börner A; Stelzner A; Günther K; Fünfstück R; Keil E; Lauterbach H Int J Artif Organs; 1982 Mar; 5(2):105-9. PubMed ID: 7095880 [TBL] [Abstract][Full Text] [Related]
13. Properties of agarose-encapsulated adsorbents. I. Adsorption of digoxin from human serum. Holloway CJ; Harstick K; Brunner G; Haeger I Biomater Med Devices Artif Organs; 1981; 9(3):167-80. PubMed ID: 7332776 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. I. Off dialysis. van der Vijgh WJ Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):249-54. PubMed ID: 881276 [No Abstract] [Full Text] [Related]
17. Elimination of digoxin during maintenance haemodialysis. Iisalo E; Forsström J Ann Clin Res; 1974 Aug; 6(4):203-6. PubMed ID: 4429332 [No Abstract] [Full Text] [Related]
18. Massive digitoxin intoxication. Treatment of Amberlite XAD 4 resin hemoperfusion. Mathieu D; Gosselin B; Nolf M; Dupuis B; Marchandise X; Boidein M; Wattel F J Toxicol Clin Toxicol; 1982 Nov; 19(9):931-50. PubMed ID: 7182522 [TBL] [Abstract][Full Text] [Related]